98 related articles for article (PubMed ID: 22665576)
41. Effect of a mass screening program on the risk of cervical cancer.
Hakama M; Räsänen-Virtanen U
Am J Epidemiol; 1976 May; 103(5):512-7. PubMed ID: 1274953
[TBL] [Abstract][Full Text] [Related]
42. Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.
Seppä K; Pitkäniemi J; Malila N; Hakama M
BJOG; 2016 Apr; 123(5):772-8. PubMed ID: 26599730
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences.
Chen YY; You SL; Chen CA; Shih LY; Koong SL; Chao KY; Hsiao ML; Hsieh CY; Chen CJ;
Br J Cancer; 2009 Jul; 101(1):174-7. PubMed ID: 19536091
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.
Sasieni P; Castanon A; Cuzick J
BMJ; 2009 Jul; 339():b2968. PubMed ID: 19638651
[TBL] [Abstract][Full Text] [Related]
45. Cervical Cancer Screening Participation among Women of Russian, Somali, and Kurdish Origin Compared with the General Finnish Population: A Register-Based Study.
Idehen EE; Virtanen A; Lilja E; Tuomainen TP; Korhonen T; Koponen P
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33126544
[TBL] [Abstract][Full Text] [Related]
46. [Cytological screening for cervical cancer in the Transcarpathian region].
Kenïdra AIu; Feĭsa SV
Wiad Lek; 2014; 67(2 Pt 2):192-5. PubMed ID: 25796823
[TBL] [Abstract][Full Text] [Related]
47. Cervical cancer screening.
S Afr Med J; 1977 Feb; 51(6):150. PubMed ID: 757956
[No Abstract] [Full Text] [Related]
48. How much cervical cancer is being prevented?
Mitchell HS
Med J Aust; 2003 Mar; 178(6):298. PubMed ID: 12633490
[No Abstract] [Full Text] [Related]
49. Estimating the impact of prevention action: a simulation model of cervical cancer progression.
Rosen-Zvi M; Shpigelman L; Kalton A; Weissbrod O; Akindeinde S; Benefeldt S; Bentley A; Everett T; Jajinskiji J; Kweyu E; Neti C; Saab J; Stewart O; Ward M; Xie GT
Stud Health Technol Inform; 2014; 205():288-92. PubMed ID: 25160192
[TBL] [Abstract][Full Text] [Related]
50. Screening older women for cervical cancer saves lives.
Printz C
Cancer; 2014 Jun; 120(11):1599. PubMed ID: 24844820
[No Abstract] [Full Text] [Related]
51. The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology.
de Kok IMCM; Burger EA; Naber SK; Canfell K; Killen J; Simms K; Kulasingam S; Groene E; Sy S; Kim JJ; van Ballegooijen M
Med Decis Making; 2020 May; 40(4):474-482. PubMed ID: 32486894
[No Abstract] [Full Text] [Related]
52. Cervical cancer: screening and risk with age.
Burki TK
Lancet Oncol; 2014 Mar; 15(3):e107. PubMed ID: 24809087
[No Abstract] [Full Text] [Related]
53. Erratum to: Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
BMC Public Health; 2015 Sep; 15():893. PubMed ID: 26369568
[No Abstract] [Full Text] [Related]
54. Correction: Screening for Cervical Cancer.
Ann Intern Med; 2013 Jun; 158(11):852. PubMed ID: 24789755
[No Abstract] [Full Text] [Related]
55. Cervical cancer in Region Skåne, Sweden 2017-2020 after the implementation of primary HPV screening: A quality assurance audit.
Hellsten C; Holmberg A; Astrom J; Forslund O; Borgfeldt C
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):129-137. PubMed ID: 37817563
[TBL] [Abstract][Full Text] [Related]
56. Effect of Test History at Ages 50-64 on Later Cervical Cancer Risk: A Population-based Case-control Study.
Kultalahti H; Heinävaara S; Sarkeala T; Pankakoski M
Cancer Res Commun; 2023 Sep; 3(9):1823-1829. PubMed ID: 37700796
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of Cervical Testing in and outside a Screening Program-A Case-Control Study.
Pankakoski M; Sarkeala T; Anttila A; Heinävaara S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358612
[TBL] [Abstract][Full Text] [Related]
58. Concordant physician-patient characteristics lose importance for Arab American women and their healthcare- cross-sectional study.
Harper DM; Sen A; Tariq M; Khoury CE; Haro EK; Alman E; Patel MR; Resnicow K
Lancet Reg Health Am; 2022 Jun; 10():. PubMed ID: 35765541
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus self-sampling with mRNA testing benefits routine screening.
Auvinen E; Nieminen P; Pellinen J; Dillner J; Tarkkanen J; Virtanen A
Int J Cancer; 2022 Dec; 151(11):1989-1996. PubMed ID: 35716139
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
